Disciplined Investments, LLC Novartis Ag Transaction History

Disciplined Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 22, 2022	SELL	$80.11 - $90.62 $16,022 - $18,124	-200 Reduced 95.24%	10 $1,000
Q4 2021 Jan 20, 2022	BUY	$79.7 - $88.13 $15,940 - $17,626	200 Added 2000.0%	210 $18,000
Q1 2021 May 12, 2021	SELL	$83.5 - $98.47 $835 - $984	-10 Reduced 50.0%	10 $1,000
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $15,379 - $18,602	-197 Reduced 90.78%	20 $2,000
Q3 2020 Nov 05, 2020	SELL	$82.14 - $91.0 $1,642 - $1,820	-20 Reduced 8.44%	217 $19,000
Q4 2019 May 19, 2020	BUY	$84.35 - $95.37 $19,990 - $22,602	237 New	237 $22,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $216B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Disciplined Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Disciplined Investments, LLC with notifications on news.